APA (7th ed.) Citation

Ciftel, S., Çiftel, S., Baykan, A. R., Cerrah, S., Çiftel, E., & Mercantepe, F. Cardiometabolic risk in non-diabetic metabolic dysfunction-associated steatotic liver disease (MAFLD) patients: Insights from the triglyceride-glucose, plasma atherogenic, and cardiometabolic index. Termedia Publishing House.

Chicago Style (17th ed.) Citation

Ciftel, Sedat, Serpil Çiftel, Ahmed R. Baykan, Serkan Cerrah, Enver Çiftel, and Filiz Mercantepe. Cardiometabolic Risk in Non-diabetic Metabolic Dysfunction-associated Steatotic Liver Disease (MAFLD) Patients: Insights from the Triglyceride-glucose, Plasma Atherogenic, and Cardiometabolic Index. Termedia Publishing House.

MLA (9th ed.) Citation

Ciftel, Sedat, et al. Cardiometabolic Risk in Non-diabetic Metabolic Dysfunction-associated Steatotic Liver Disease (MAFLD) Patients: Insights from the Triglyceride-glucose, Plasma Atherogenic, and Cardiometabolic Index. Termedia Publishing House.